Liang Cheng

Zhejiang University of Technology — China

Medicine · Health Sciences

43h-index5.5kcitations240works17.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bladder and Urothelial Cancer Treatments(153), Urinary and Genital Oncology Studies(111), Urological Disorders and Treatments(38), Testicular diseases and treatments(23), Epigenetics and DNA Methylation(19)

Publications240 total

Online parameter identification of AUV horizontal model based on Sparse Bayesian Learning
Measurement·2026
[Hepatic carcinoma with NIPBL::NACC1 fusion: report of a case].
PubMed·2025
An algorithm for personalized optimal acetabular cup implant positioning based on bony coverage rate and impingement-free range of motion
Medical & Biological Engineering & Computing·2025
The COPD risk associated with adulthood weight change and early adulthood BMI: a prospective cohort study
BMC Public Health·2025Open Access
Expanded mosaic chromosomal alterations, frailty, and risks of all-cause and cause-specific mortality among Chinese and the UK adults: evidence from two prospective cohorts
BMC Medicine·2025Open Access
Prostate Cancer Grading
Urologic Clinics of North America·2025
Perivascular epithelioid cell tumors of the urinary bladder: a multi-institutional clinicopathologic and molecular analysis of 21 cases
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin·2025· 1 citedOpen Access
Genetic profiling of upper tract urothelial carcinoma: A necessity for precision medicine
Expert Review of Molecular Diagnostics·2025
Recent advances in nanotechnology for metabolic cancer therapy
Coordination Chemistry Reviews·2025· 3 cited
Isolation and Identification of herbicidal active substances of Botrytis strain HZ-011
Plant Protection Science·2025· 1 citedOpen Access
Distinct protein-protein interactions define papillary and non-papillary urothelial carcinoma architectures (Preprint)
2025Open Access
Molecular testing in urinary cytology specimens: Current status and future directions
Urologic Oncology Seminars and Original Investigations·2025· 2 cited
821 Post-therapeutic Squamous Cell Transformation of Metastatic Prostatic Adenocarcinoma with Paired Molecular Profiling: A Multi-Institutional Cohort of an Under-reported Entity
Laboratory Investigation·2025
893 Interobserver Reproducibility of Pelvicalyceal Invasion in Renal Cell Carcinomas Among Genitourinary Pathologists
Laboratory Investigation·2025Open Access
776 POLE-Ultramutated Prostatic Carcinoma: a Rare Molecularly Defined Prostate Cancer Subtype With Potential for Durable Response to Immunotherapy
Laboratory Investigation·2025· 1 citedOpen Access
844 Perivascular Epithelioid Cell Tumors of the Urinary Bladder: A Clinicopathologic and Comprehensive Molecular Analysis including Microsatellite Instability Status and Tumor Mutational Burden in a Contemporary Cohort of 21 cases
Laboratory Investigation·2025
MALIGNANT EPITHELIOID ANGIOMYOLIPOMA (EAML)/PECOMA OF THE KIDNEY: A COMPREHENSIVE GENOMIC PROFILING (CGP) STUDY
Urologic Oncology Seminars and Original Investigations·2025
<i>MTAP</i> loss in primary kidney tumors: A comprehensive genomic profiling study.
Journal of Clinical Oncology·2025
The anti-melanoma roles and mechanisms of tricholoma isoflavone derivative CA028
npj Science of Food·2025· 2 citedOpen Access
Darkcyclegan: A De-Raining Algorithm Based on Dark Channel Attention and Cyclegan
SSRN Electronic Journal·2025Open Access
page 1 of 12Next →

Frequent Co-authors

David G. Bostwick(12), Michael O. Koch(10), John N. Eble(9), Thomas M. Ulbright(9), Roxann M. Neumann(8), John C. Cheville(8), Gregory T. MacLennan(7), Shaobo Zhang(7), Bradley C. Leibovich(7), Timothy D. Jones(6), Richard S. Foster(6), Amy L. Weaver(5), Horst Zincke(5), Ajay Nehra(4), Dharamdas M. Ramnani(4), Jun Lv(4), Hristos Z. Kaimakliotis(4), Jose A. Pedrosa(4), Richard Bihrle(4), Ming‐Sheng Wang(3)